CYP3A4 inhibitors are compounds that can reduce or completely halt the activity of the CYP3A4 enzyme. By inhibiting this enzyme, these compounds can increase the plasma concentrations of drugs that are CYP3A4 substrates, leading to enhanced therapeutic effects or potentially dangerous side effects. In cancer therapy, CYP3A4 inhibitors can be used to increase the effectiveness of certain chemotherapeutic agents.
